baber/WOPTO huggingface dataset:
Patent EP-1178333-A2 (EP)
Inventor: RAY LAWRENCE A
IPC: G01S17/89
Filed: 2001-07-23
Abstract: A color scannerless range imaging system includes an illumination
system for illuminating the scene with modulated illumination of a predetermined
modulation frequency and an image capture section positioned in an optical path
of the reflected illumination from the scene for capturing a plurality of images
including (a) at least one range image corresponding to the reflected modulated
illumination and including a phase delay corresponding to the distance of objects
in the scene from the range imaging system, and (b) at least one other image of
reflected unmodulated illumination corresponding to color in the scene. The
image capture section includes a color filter array arranged with a first type of
color filter that preferentially transmits the reflected modulated illumination and
one or more other color filters that preferentially transmit the reflected
unmodulated illumination, an image intensifier receiving the reflected
illumination and including a modulating stage for modulating the reflected
modulated illumination from the scene, thereby generating the range information,
and an image responsive element for capturing an output of the image intensifier,
including the range image and the other image of reflected unmodulated image
light corresponding to color in the scene. The image intensifier is structured with
channels that generally correspond to the color filter array such that the intensifier
provides the range image from channels corresponding to the first color filter and
the other image corresponding to color in the scene from channels corresponding
to the other color filters.
Patent EP-1197535-A2 (EP)
Inventor: EVANS STEVEN
IPC: C09D11/00
Filed: 2001-10-01
Abstract: An ink jet ink composition comprising water, a humectant and a
water-soluble pyrazoleazoindole dye.
Patent EP-1193910-A2 (EP)
Inventor: FORSSELL MIKA
IPC: H04L12/56
Filed: 2000-01-11
Abstract: A method is presented for establishing a continued communication
connection after a terminating communication connection between a
transmitting station and a receiving station in a communication system
where communication connections take place on dedicated
communication resources temporarily associated to them. The
termination of the terminating communication connection is indicated
through a communication resource associated to the terminating
communication connection (304, 404, 405, 504). The need for a
continued communication connection is also indicated through a
dedicated communication resource (305, 408, 408', 509).
Patent EP-1130261-A2 (EP)
Inventor: HUANG YONG
IPC: F25B9/00
Filed: 2001-02-20
Abstract: A vehicular air conditioning system (10) includes a
compressor (110) having a crank chamber (138), a suction
chamber (120), and a discharge chamber (122). A
refrigerant mixture includes carbon dioxide and oil. A
conduit (13) connects the discharge chamber (122) of the
compressor (110) directly with an oil separator (14) to
route the refrigerant mixture directly to the oil
separator (14). Only a restricted orifice (16) is
provided between the oil separator (14) and the crank
chamber (138) of the compressor (110) to throttle oil as
it travels directly to the crank chamber (138) of the
compressor (110).
Patent EP-1128269-A2 (EP)
Inventor: KIRIHATA TOSHIAKI
IPC: G11C11/401
Filed: 2001-02-23
Abstract: A memory device that includes a plurality of data storage cells; at least
one redundancy data storage cell; a redundancy match detection circuit; and a
means for coupling programmable fuses to the redundancy match detection
circuit, wherein a defective data storage is replaced by one redundancy data
storage when the redundancy match detection detects a pre-determined
condition set by said programmable fuse is described. Decoding is accomplished
by a data bus selecting the e-fuse to be blown. The data bus is also used for
reading the state of the e-fuses to ensure that the e-fuses are correctly blown.
Power is effectively applied to the selected e-fuses while sharing the data bus
for e-fuse decoding and verification. In order to reduce the number of
communication channels between e-fuses and the redundancy match detection
circuitry, the transfer operation uses time multiplexing, allowing e-fuse
information to be transferred to the redundancy match detection circuitry
sequentially. The actual time multiplexing operation for performing the transfer
is preferably enabled only after the chip power-up state.
Patent EP-1191739-A2 (EP)
Inventor: DUVAL DONALD E
IPC: H04L9/06
Filed: 2001-09-21
Abstract: A system for encrypting and decrypting data formed of a number of bytes
using the ARCFOUR encryption algorithm is disclosed. The system includes a
system bus and an encryption accelerator arranged to execute the encryption
algorithm coupled to the system bus. A system memory coupled to the system bus
arranged to store a secret key array associated with the data and a central processing
unit coupled to the system bus wherein encryption accelerator uses substantially no
central processing unit resources to execute the encryption algorithm.
Patent EP-1258901-A2 (EP)
Inventor: ISOHATA HIDEKI
IPC: H01J17/49
Filed: 2001-12-07
Abstract: A structure, in which the frame can be successfully
fixed to the plasma display apparatus at a low cost, has
been disclosed. The plasma display apparatus comprises a
plasma display panel, circuit substrates having drive
circuits to drive the plasma display panel, a main frame
to mount the circuit substrates, and adhesive tapes to
fix the plasma display panel to the main frame, and small
holes are provided on the portion to which the adhesive
tapes of the main frame are fixed so that they are
arranged regularly at established intervals. When the
adhesive tapes and the main frame are fixed, no air
bubbles form between the adhesive tapes and the main
frame because plural small holes are provided on the
portion to which the adhesive tapes of the main frames
are fixed.
Patent EP-1250634-A2 (EP)
Title: Systeme et appareil pour fournir un ecoulement de fluide
Inventor: BRIGGS DENNIS
IPC: G05D11/13
Filed: 2001-01-10
Abstract: L'invention concerne un procédé, un appareil et un système pour combiner un premier fluide biologique à un deuxième fluide biologique pour produire un mélange des premier et deuxième fluides biologiques qui peut être ajusté et maintenu pour obtenir un rapport requis. Les applications particulières peuvent comprendre l'aphérèse, la chimiothérapie, la dialyse et la fabrication de préparations pharmaceutiques ou chimiques. Cet appareil comprend des conduites de sous-composants, des moyens formant clapets, des moyens de pression, et d'indication de pression et des cellules de charge. Ce système peut présenter de nombreux éléments de rétroaction pour contrôler avec précision la pression, les débits et la quantité de fluide traité.
Patent EP-1259246-A2 (EP)
Title: Inhibition de la degenerescence des cellules beta
Inventor: CARR RICHARD DAVID
IPC: A61K31/00
Filed: 2001-02-20
Abstract: La présente invention concerne un procédé pour empêcher la dégénérescence des cellules bêta, par exemple, la nécrose ou l'apoptose des cellules bêta chez un sujet; le procédé consiste à administrer à l'individu un inhibiteur de DPP-IV. L'invention concerne en outre un procédé pour augmenter le nombre et/ou la taille des cellules bêta. Elle se rapporte également à un procédé pour freiner la progression de l'intolérance au glucose vers le diabète de type 2 ainsi qu'un procédé pour retarder la progression du diabète de type 2 non insulino-dépendant vers le diabète de type 2 insulino-dépendant.
Patent EP-1248985-A2 (EP)
Title: Systeme et procede destines a ameliorer la communication entre des dispositifs dans un systeme informatique
Inventor: WOOD DAVID A
IPC: G06F13/42
Filed: 2001-01-18
Abstract: L'invention concerne un appareil et un procédé de renvoi d'une demande dans un système informatique au moyen d'une valeur de retard. En réponse à la réception d'une demande, le dispositif cible d'un système informatique est en mesure de détecter qu'il est temporairement impossible de traiter la demande. Ce dispositif cible peut envoyer une réponse au dispositif d'envoi pour l'informer de son indisponibilité temporaire. La réponse peut contenir une valeur de retard, laquelle peut fournir une indication au dispositif d'envoi en ce qui concerne le moment auquel la demande peut être renvoyée. Le dispositif cible génère une valeur de retard selon le type de condition causant son indisponibilité temporaire. La valeur de retard peut être générée selon une heuristique statique ou un algorithme dynamique fonction des conditions d'indisponibilité temporaire préalables. La valeur de retard peut également être utilisée par un mécanisme de correction d'erreurs lorsqu'un dispositif d'envoi dépasse une limite d'essais de renvoi pour une demande particulière.
Patent EP-1296923-A2 (EP)
Inventor: SERHAN CHARLES N
IPC: A61P11/00
Filed: 2001-02-16
Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment or prevention of inflammation associated with various diseases, including ischemia.
Patent EP-1355670-A2 (EP)
Inventor: LAM ANGELA M I
IPC: A61K47/48
Filed: 2001-04-20
Abstract: The present invention provides effective compositions, methods and uses for delivering nucleic acids to cells. The inventive compositions and methods are based upon the surprising discovery that the presence of an endosomal membrane destabiliser in a lipid formulation leads to a dramatic increase in transfection efficiency. The present compositions and methods can be used in vitro or in vivo, and can be used to increase the transfection efficiency of any cell type, including mammalian cells (e.g., humans). In certain embodiments, the conjugated lipid that inhibits aggregation is a 'cationic polymer lipid' (CPL). In preferred aspects, the CPL has the formula (I). In formula (I), A is a lipid moiety, W is a hydrophilic polymer, and Y is a polycationic moiety. In certain preferred embodiments, Y is selected from lysine, arginine, asparagine, glutamine, and combinations thereof. In another embodiment, the present invention provides a method for introducing a nucleic acid into a cell, comprising contacting the cell with a nucleic acid-lipid particle composition, wherein the particle comprises a cationic lipid, a conjugated lipid that inhibits aggregation of particles, a nucleic acid; and an endosomal membrane destabilizer. The endosomal membrane destabilizer can be inside the particle, outside the particle, or both inside and outside the particle. In certain embodiments, the endosomal membrane destabilizer contacts the cell before the particle, after the particle, simultaneously or combinations thereof. In still another embodiment, the present invention provides a method for inducing HII phase structure in a lipid bilayer, comprising contacting the lipid bilayer with an endosomal membrane destabilizer, thereby inducing HII phase structure in the lipid bilayer. In certain aspects, the endosomal membrane destabilizer (e.g., Ca++ion) acts synergistically or additively with low levels of the cationic lipid to trigger H¿II? phase formation.
Patent EP-1254271-A2 (EP)
Inventor: GOLDSBOROUGH MINDY D
IPC: C12Q1/68
Filed: 2001-01-10
Abstract: L'invention concerne le stockage d'acides nucléiques (en particulier d'ARNm) sur un support solide, et l'utilisation de ces acides nucléiques dans la synthèse d'acides nucléiques ou dans des réactions d'amplification. Dans un mode de réalisation préféré, l'invention concerne la synthèse de c-ADN et des bibliothèques de c-ADN.
Patent EP-1307558-A2 (EP)
Inventor: BOWMAN MICHAEL R
IPC: C07K14/705
Filed: 2001-08-03
Abstract: Novel EBI-3-alt polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length EBI-3-alt proteins, the invention further provides isolated EBI-3-alt fusion proteins, antigenic peptides and anti-EBI-3-alt antibodies. The invention also provides EBI-3-alt nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which an EBI-3-alt gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
Patent EP-1326935-A2 (EP)
Inventor: OVERBEEK GERARDUS CORNELIS
IPC: C08F257/02
Filed: 2001-10-01
Abstract: An aqueous dispersion comprising an alkyd, vinyl polymer I, vinyl polymer II and a liquid medium where vinyl polymer I is preformed prior to incorporation into the aqueous dispersion and where vinyl polymer II is prepared in the presence of the alkyd and the vinyl polymer I.
Patent EP-1280929-A2 (EP)
Inventor: NEMEROW GLEN R
IPC: A61K48/00
Filed: 2001-04-30
Abstract: Cette invention concerne des méthodes de thérapie génique à base de vecteurs adénoviraux pour le traitement de troubles oculaires. L'invention concerne également des vecteurs adénoviraux pour la thérapie de pathologies de l'oeil et des méthodes de traitement faisant intervenir ces vecteurs. De plus, l'invention porte sur des compositions, des trousses et des méthodes de préparation et d'utilisation desdits vecteurs pour thérapie génique.
Patent EP-1350288-A2 (EP)
Title: Laser emitter
Inventor: GALLHUBER ANTON
IPC: H01S5/02
Filed: 2001-09-26
Abstract: The invention relates to a laser emitter, in particular, for free space data transmission and/or weapon simulators, comprising a laser diode (11), generating a laser beam (10) from laser impulses and an emitter lens (13), arranged after the laser diode (11) in the beam path, for influencing the beam profile (15) and the intensity distribution in the beam profile (15). In order to achieve a high range with an effective area (16) of the laser beam (10) almost constant over distance, the emitter lens (13) is so arranged that the intensity in the beam profile (15) falls away, as a square of the separation (r), from a spatially limited intensity maximum in the centre of the profile out towards the profile edge.
Patent EP-1336295-A2 (EP)
Title: Systeme et procede permettant de fournir un contenu interactif pertinent a un ecran de radiodiffusion
Inventor: SPRAGUE MICHAEL
IPC: H04N5/445
Filed: 2001-10-19
Abstract: L'invention concerne un système et un procédé (10) permettant d'afficher un contenu interactif (58) se rapportant à une présentation de radiodiffusion (20) sur un écran (16) de visualisation associé à un dispositif de visualisation. Le procédé démarre par la réception, par le dispositif de visualisation (16), d'une présentation de radiodiffusion transmise par un fournisseur de présentations de radiodiffusion. Ensuite, le dispositif de visualisation reçoit le contenu interactif (58) pertinent transmis par une source (44) de contenus interactifs, lequel contenu est filtré et personnalisé pour un utilisateur spécifique. Ce contenu supplémentaire est relié au contenu de radiodiffusion par le simple fait d'un mappage de pertinence. Ainsi, le contenu peut être présenté à l'utilisateur sans l'aide directe du fournisseur de présentations de radiodiffusion. Le dispositif (16) fusionne la présentation de radiodiffusion (20) et le contenu interactif (58) puis il les affiche sur le dispositif de visualisation (16). De préférence, le dispositif (16) accède à la source (44) par l'intermédiaire d'un réseau informatique (40), tel qu'Internet.
Patent EP-1339427-A2 (EP)
Title: Procede de production de molecules bispecifiques par transepissage de proteines
Inventor: HIMAWAN JEFF
IPC: A61P31/04
Filed: 2001-11-01
Abstract: La présente invention concerne des procédés mettant en oeuvre le transépissage de protéines pour la production d'une molécule bispécifique présentant une première portion de reconnaissance d'antigènes de liaison à un récepteur du type C3b et une deuxième portion de reconnaissance d'antigènes de liaison à une molécule antigénique se trouvant dans le système circulatoire d'un mammifère. L'invention concerne également de molécules bispécifiques obtenus par transépissage de protéines. Les molécules bispécifiques de l'invention peuvent être utilisées pour l'élimination de molécules antigéniques pathogènes du système circulatoire d'un mammifère. L'invention concerne en outre des procédés de mise en oeuvre de transépissage de protéines pour la production de bibliothèques polyclonales de molécules bispécifiques, comprenant des populations de molécules bispécifiques à spécificités différentes de reconnaissance d'antigènes. De telles bibliothèques polyclonales de molécules bispécifiques peuvent être utilisées pour le ciblage de multiples épitopes d'une molécules antigénique pathogène et/ou de multiples variants d'une molécule antigénique pathogène.
Patent EP-1338146-A2 (EP)
Inventor: AARTS RONALDUS M
IPC: H04N5/00
Filed: 2001-11-07
Abstract: One of the items that is coming up lately is that the content information is coded before it has been sent to the user. The user of the content information only wants to pay for the content information when he knows for what content information he is paying. So, this dilemma exists between the producer (SEN) and the user (RD) of content information. The invention provides a method and a device (SEN) able to supply coded content (cci) information and at the other hand giving the user the possibility to decide whether or not he wants to receive (req) the decoded content information (dc). After decoding the content information the user can listen or view the content information (co) at full quality.
Patent EP-1352259-A2 (EP)
Inventor: PATWARI NEAL K
IPC: G01S3/02
Filed: 2001-12-19
Abstract: A system for locating a number of devices (112-130) by measuring signals transmitted between known location devices (112-118, 134-138, 214-218, 224-228) and unknown location devices (120-130, 222), and signals transmitted between pairs of unknown location devices (120-130,222), entering signal measurements into a graph function that includes a number of first sub-expressions, a number of which include signal measurement prediction sub-expressions, and have extrema when a predicted signal measurement is equal to an actual signal measurement, and optimizing the graph function.
Patent EP-1235285-A2 (EP)
Inventor: SCHREINER HANS-JUERGEN DR
IPC: H02N2/02
Filed: 2002-02-18
Abstract: For the manufacture of multilayer actuators, the laminate is split into several actuators, which are pyrolized and then sintered. Because lamination in the unsintered body often produces non-homogeneity in the density, and the shrinkage during the firing of the ceramic is not of a constant value, the final geometry of the actuators can only be accurately obtained by the hardening of the sintered actuators. But in this case the internal electrode layers deposited in the actuators are thereby also processed, which can cause electrical flashovers and leakage currents during operation. Thus, according to the invention, a procedure is provided in which the block of the stacked green films provided with internal electrodes is laminated, that at least one actuator is separated from the block, that the actuator obtains its shape by means of a machining operation, that it is then sintered, that the sinter skin produced by the sintering is used as an insulating layer and that the sinter skin is abraded at the points where the internal electrodes are connected to the external electrodes.
Patent EP-1273264-A2 (EP)
Inventor: NARIMATSU KIYOYUKI
IPC: A61B5/0245
Filed: 2002-02-25
Abstract: An apparatus (10) for evaluating a degree of arteriosclerosis of a
living subject, comprising a pulse-wave-propagation-velocity-related-information
obtaining device (30,74,76,78) which
obtains pulse-wave-propagation-velocity-related information;
a pulse-wave sensor (30) which is adapted to be worn on
a body portion of the subject and detects the pulse wave from the
body portion; an augmentation-related-information obtaining
means (80) for obtaining augmentation-related information that
is related to an augmentation of an amplitude of the pulse wave
detected by the pulse-wave sensor from an amplitude of an
incident-wave component which is contained in the pulse wave;
and an arteriosclerosis evaluating means (82) for evaluating the
degree of arteriosclerosis of the subject, based on
a prescribed relationship (86) between (A) (a1) pulse-wave-propagation-velocity-related
information and (a2) augmentation-related
information and (B) degree of arteriosclerosis.
Patent EP-1246327-A2 (EP)
Inventor: YOSHIDA TAKESHI
IPC: H01S5/0683
Filed: 2002-03-13
Abstract: According to the present invention, an optical output automatic control circuit
includes an optical output cutoff control circuit (4) outside its feedback loop, and
sets an optical output setting voltage at the ground level to prevent overshooting
of the optical output while an optical output cutoff signal is being input.
Patent EP-1260158-A2 (EP)
Inventor: HELD WOLFGANG
IPC: A47B88/00
Filed: 2002-04-10
Abstract: The furniture drawer (2) can be mounted in a furniture carcass in a manner such that it can be pilled out. An electrical energy transmitter is provided to send electrical energy to the rechargeable battery (3) arranged in or on the drawer. An Independent claim is included for the furniture to which the furniture is installed.
Patent EP-1255370-A2 (EP)
Inventor: BAUERSCHMIDT WERNER
IPC: H04L5/02
Filed: 2002-04-24
Abstract: The method involves using a number of carrier frequencies for transmitting data by the high data rate equipment (100-102) and using a single carrier frequency for data transmission and reception by the low data rate devices (200). The high data rate equipment send and receive data with high and low data rates. Independent claims are also included for the following: a system with at least one high data rate messaging device and at least one low data rate one and messaging equipments for high and low data rates.
Patent EP-1253708-A2 (EP)
Inventor: OKUBO YOICHI
IPC: H03F1/32
Filed: 2002-04-26
Abstract: There is provided a distortion canceling circuit for
reducing an unbalance between a higher and a lower 3rd order
distortion at frequencies of (2·f2-f1) and (2·f1-f2),
respectively, the distortions being generated by an
amplifier which amplifies an input signal having at least
two frequency components, i.e., f1 and f2. Phase modulation
control means supply a control signal, which has a
difference frequency of (f2-f1), to phase modulation means,
the control signal being generated based on the amplified
input signal outputted from the amplifier. The phase
modulation means performs phase modulation on the amplified
input signal based on the supplied control signal to thereby
generate a higher and a lower side-band signal having
frequencies of (2·f2-f1) and (2·f1-f2), respectively, each
of which has an identical amplitude and a phase difference
of 180° with respect to each other. The distortion
canceling circuit reduces the unbalance by using the side-band
signals.
Patent EP-1275940-A2 (EP)
Inventor: BUDMIGER THOMAS
IPC: G01F1/60
Filed: 2002-04-30
Abstract: A voltage is induced in a moving fluid to change the potentials applied to the electrodes (12,13) at a flow tube. A measurement signal is derived from the induced voltage by picking off the potentials applied to the electrodes. Excitation current flows through the field coils (14,15) when fluid flows through the flow tube, generating partial magnetic fields that cut through the fluid. The strength of at least one excitation current is varied so that the average strengths of the partial magnetic fields are at least temporarily different from each other. The polarity of one excitation current is reversed for the two partial magnetic fields to be temporarily directed opposite to each other. An Independent claim is also included for an electromagnetic flowmeter.